XtalPi
Business Services · China · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Second Phase of the International 3/f Bi...Phone Number
+86 75581901777Website
www.xtalpi.comRevenue
$117.7 MillionStock Symbol
2228.HKIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About XtalPi
Founded in 2014, XtalPi is a biotech firm that uses artificial intelligence and computing to accelerate the development of new drugs. The firm uses algorithms to predict the crystalized form a drug will take. The data enables XtalPi to work with other pharmaceutical companies to develop new drugs and create new patents.XtalPi is located in ChinaExplore more
XtalPi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XtalPi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
XtalPi, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when XtalPi launches new products
Earning: See what the market has to say on XtalPi recently announced quarterly report
Check out if XtalPi is spiking on competitors!
Check if XtalPi has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at XtalPi
Click to see if XtalPi had a recent Job posting/layoffs
Funding: Get notified immidiatlly once XtalPi has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
XtalPi is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
XtalPi is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about XtalPi.
XtalPi financials insights
Gather financial insights about XtalPi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$5M
2020
Series C
$318.8M
2021
Series B
$61M
Series D
$400M
XtalPi Tech Stack
A closer look at the technologies used by XtalPi
Most Recent Scoops
Pain Point
Project
, according to a mid-level source in sales, is planning to remediate challenges related to reaching targeted prospects. XtalPi is planning to update workflow.
Pain Point, Sales, Lead Management, Customer Marketing
Pain Point
Project
, according to a mid-level source in sales, is planning to remediate challenges related to generating more leads and pipeline. The organization is working on a new targeting strategy to support these remediation efforts.
Pain Point, Sales, Lead Management, Sales Development
Pain Point
Project
, according to a mid-level source in sales, is planning to remediate challenges related to introducing new products. XtalPi is planning to update workflow.
Pain Point, Product Marketing, Product Development, Product Management, Sales
Open Position
Hiring Plans
Hiring Plans
XtalPi News & Media
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
BOSTON, May 29, 2026 /PRNewswire/ -- XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company DoveTree Medicines Unus Inc. has achieved substantial progress, and that XtalPi has received...Accelerating Drug Discovery: Leveraging XtalPi’s Intelligent Software for Faster Breakthroughs
BOSTON, MA, UNITED STATES, May 29, 2026 /EINPresswire.com/ -- The pharmaceutical industry is currently undergoing a paradigm shift as the traditional, labor-intensive models of drug development are being replaced by data-driven, automated ecosystems. …XtalPi: Defining the Next-Generation R&D Paradigm Through AI for Science
BOSTON, MA, UNITED STATES, May 29, 2026 /EINPresswire.com/ -- The methods that drive scientific discovery are undergoing a quiet but substantial transformation. Empirical, iterative experimentation has driven extraordinary progress across biopharma, …XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
SHENZHEN, China, May 4, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine (4162.TWO) PEP08, a next-generation PRMT5 inhibitor discovered via XtalPi's platform, has successfully begun enrollments in a Phase I solid tumor trial, achieving a new clinical milestone. Built upon the success of PEP08 at the drug discovery stage, the two companies initiated a second project, tar
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding XtalPi
Sign Up For FreeTo access detailed company insights
Founded in 2014, XtalPi is a biotech firm that uses artificial intelligence and computing to accelerate the development of new drugs. The firm uses algorithms to predict the crystalized form a drug will take. The data enables XtalPi to work with other pharmaceutical companies to develop new drugs and create new patents.XtalPi is located in China... Read More
